Showing results (311-320 of 370) with videos related to
Sort By:
Pageof 37
Stem Cells (Dayton, Ohio)|June 3, 2009
A methodological approach to tracing cell lineage in human epithelial tissuesTariq G Fellous, Stuart A C McDonald, Julia Burkert, et al.Journal of Medical Genetics|January 27, 2019
Diagnosis of 'possible' mitochondrial disease: an existential crisisSumit Parikh, Amel Karaa, Amy Goldstein, et al.Journal of Neurology|September 12, 2014
SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotypeKathryn J Peall, Manju A Kurian, Mark Wardle, et al.Nature Communications|July 4, 2014
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasiaVeronika Boczonadi, Juliane S Müller, Angela Pyle, et al.Annals of the Rheumatic Diseases|September 18, 2012
No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controlsGavin Hudson, Kalliope Panoutsopoulou, Ian Wilson, et al.The Lancet. Neurology|June 17, 2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension studyThomas Klopstock, Fernando Tricta, Lynne Neumayr, et al.Brain : a Journal of Neurology|October 16, 2012
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathyStephan Klebe, Christel Depienne, Sylvie Gerber, et al.Brain : a Journal of Neurology|February 1, 2013
SGCE mutations cause psychiatric disorders: clinical and genetic characterizationKathryn J Peall, Daniel J Smith, Manju A Kurian, et al.American Journal of Human Genetics|August 2, 2007
Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup backgroundGavin Hudson, Valerio Carelli, Liesbeth Spruijt, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2012
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's diseaseLaura L Kilarski, Justin P Pearson, Victoria Newsway, et al.Pageof 37